Liver damage profile in COVID-19 pregnant patients

被引:2
|
作者
Januszewski, Marcin [1 ]
Ziuzia-Januszewska, Laura [2 ]
Kudan, Michal [1 ]
Pluta, Kamil [1 ]
Klapaczynski, Jakub [3 ]
Wierzba, Waldemar [1 ]
Maciejewski, Tomasz [4 ]
Jakimiuk, Alicja A. [5 ]
Jakimiuk, Artur J. [1 ,6 ]
机构
[1] Minist Interior & Adm, Natl Med Inst, Dept Obstet & Gynecol, Woloska 137, PL-02507 Warsaw, Poland
[2] Minist Interior & Adm, Natl Med Inst, Dept Otolaryngol, Woloska 137, PL-02507 Warsaw, Poland
[3] Minist Interior & Adm, Natl Med Inst, Dept Hepatol, Woloska 137, PL-02507 Warsaw, Poland
[4] Inst Mother & Child Hlth, Dept Obstet & Gynecol, Kasprzaka 17a, PL-01211 Warsaw, Poland
[5] Minist Interior & Adm, Natl Med Inst, Dept Plast Surg, Woloska 137, PL-02507 Warsaw, Poland
[6] Inst Mother & Child Hlth, Ctr Reprod Hlth, Kasprzaka 17a, PL-01211 Warsaw, Poland
关键词
COVID-19; Liver damage; Pregnancy; Bile acids; SARS-CoV-2; SARS-COV-2; INFECTION; CHOLESTASIS;
D O I
10.1186/s12964-023-01285-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
IntroductionSARS-CoV-2 unsparingly impacts all areas of medicine. Pregnant women are particularly affected by the pandemic and COVID-19 related liver damage seems to be another threat to maternal and fetal health. The aim of this study is to define liver damage profile including bile acids serum levels in COVID-19 pregnant patients and to determine predictors of disease aggravation and poor obstetrics outcomes.MethodsThis study has been carried out in the Obstetrics and Gynecology Department, at the National Medical Institute in Warsaw, Poland between 01.02.2021 and 01.11.2022 The study cohort comprises 148 pregnant patients with COVID-19 and 102 pregnant controls who has been tested negative for SARS-CoV-2.ResultsCOVID-19 pregnant patients presented liver involvement at admission in 41,9%. Hepatotoxic damage accounted for 27 (19.85%), cholestatic type was diagnosed in 11 (8.09%) and mixed type of liver injury was presented in 19 (13.97%) of patients. Higher serum levels of AST, ALT, GGT, total bilirubin and bile acids as well as mixed type of liver injury at admission were correlated with severe form of an illness. AST and ALT above upper reference limit as well as hepatotoxic type of liver damage predisposed pregnant patients with COVID-19 to poor obstetrics outcomes.ConclusionHepatic damage in pregnant women with COVID-19 is a common, mild, transaminase-dominant, or mixed type of injury, and often correlates with elevated inflammatory markers. SARS-CoV-2 test should be performed as a part of differential diagnosis in elevated liver function tests. Although bile acids serum levels were commonly elevated they seems to be clinically irrelevant in terms of pregnancy outcomes.DaRpyovs-oA9XgYzu_a_v9Video AbstractConclusionHepatic damage in pregnant women with COVID-19 is a common, mild, transaminase-dominant, or mixed type of injury, and often correlates with elevated inflammatory markers. SARS-CoV-2 test should be performed as a part of differential diagnosis in elevated liver function tests. Although bile acids serum levels were commonly elevated they seems to be clinically irrelevant in terms of pregnancy outcomes.DaRpyovs-oA9XgYzu_a_v9Video Abstract
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Pregnant during the COVID-19 pandemic: an exploration of patients’ lived experiences
    Sabrina Kolker
    Anne Biringer
    Jessica Bytautas
    Haley Blumenfeld
    Sahana Kukan
    June C. Carroll
    BMC Pregnancy and Childbirth, 21
  • [42] Does the Fetus Limit Antibiotic Treatment in Pregnant Patients with COVID-19?
    Ramirez-Lozada, Tito
    Loranca-Garcia, Maria Concepcion
    Fuentes-Venado, Claudia Erika
    Rodriguez-Cerdeira, Carmen
    Ocharan-Hernandez, Esther
    Soriano-Ursua, Marvin A.
    Farfan-Garcia, Eunice D.
    Chavez-Gutierrez, Edwin
    Ramirez-Magana, Xochitl
    Robledo-Cayetano, Maura
    Loza-Mejia, Marco A.
    Santa-Olalla, Ivonne Areli Garcia
    Torres-Paez, Oscar Uriel
    Pinto-Almazan, Rodolfo
    Martinez-Herrera, Erick
    ANTIBIOTICS-BASEL, 2022, 11 (02):
  • [43] Evaluation of the tolerability of monoclonal antibody therapy for pregnant patients with COVID-19
    Magawa, Shoichi
    Nii, Masafumi
    Maki, Shintaro
    Enomoto, Naosuke
    Takakura, Sho
    Maegawa, Yuka
    Osato, Kazuhiro
    Tanaka, Hiroaki
    Kondo, Eiji
    Ikeda, Tomoaki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48 (09) : 2325 - 2333
  • [44] Liver profile in COVID-19: a meta-analysis
    Bansal, Abhishek
    Prasad, Jang Bahadur
    JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2022, 30 (01): : 253 - 258
  • [45] Assessment of liver damage in patients with COVID-19 is sub-optimal: results of a survey of medical practitioners
    Alventosa Mateu, Carlos
    Benlloch Perez, Salvador
    Diago Madrid, Moises
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (01) : 51 - 52
  • [46] Pregnant during the COVID-19 pandemic: an exploration of patients' lived experiences
    Kolker, Sabrina
    Biringer, Anne
    Bytautas, Jessica
    Blumenfeld, Haley
    Kukan, Sahana
    Carroll, June C.
    BMC PREGNANCY AND CHILDBIRTH, 2021, 21 (01)
  • [47] The impact of COVID-19 in pregnancy: Part I. Clinical presentations and untoward outcomes of pregnant women with COVID-19
    Wang, Peng-Hui
    Lee, Wen-Ling
    Yang, Szu-Ting
    Tsui, Kuan-Hao
    Chang, Cheng-Chang
    Lee, Fa-Kung
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2021, 84 (09) : 813 - 820
  • [48] COVID-19 Pregnant Patient Management with a Case of COVID-19 Patient with An Uncomplicated Delivery
    Ozcelik, Neslihan
    Ozdemir, Serda
    Gurlek, Beril
    Yildiz, Ilknur Esen
    TURKISH THORACIC JOURNAL, 2020, 21 (05): : 354 - 356
  • [49] Unique immunological profile in patients with COVID-19
    Varchetta, Stefania
    Mele, Dalila
    Oliviero, Barbara
    Mantovani, Stefania
    Ludovisi, Serena
    Cerino, Antonella
    Bruno, Raffaele
    Castelli, Alberto
    Mosconi, Mario
    Vecchia, Marco
    Roda, Silvia
    Sachs, Michele
    Klersy, Catherine
    Mondelli, Mario U.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (03) : 604 - 612
  • [50] Unique immunological profile in patients with COVID-19
    Stefania Varchetta
    Dalila Mele
    Barbara Oliviero
    Stefania Mantovani
    Serena Ludovisi
    Antonella Cerino
    Raffaele Bruno
    Alberto Castelli
    Mario Mosconi
    Marco Vecchia
    Silvia Roda
    Michele Sachs
    Catherine Klersy
    Mario U. Mondelli
    Cellular & Molecular Immunology, 2021, 18 : 604 - 612